Research and Markets Apoptosis Promise Or Deception



May 19, 2005 -- Research and Markets (http://www.researchandmarkets.com/reports/c17635) has announced the addition of Analytical Tool - Apoptosis: Promise Or Deception to their offering

In this Analytical Tool, understanding of the whole industrial endeavor in apoptosis as cancer therapeutic target is brought to light. Almost a hundred drug candidates are described in detail and 25 of the most advanced are analyzed for their success and failure. In all, more than 60 companies are included for their R&D activities within the field.

The five major targets in apoptosis, p53, Bcl-2, TRAIL, IAP and Caspases, are the corner stones in this Analytical Tool for further analysis whether they are successful cancer therapeutic targets or not and what level of competition is present. Only p53 and Bcl-2 are today apoptotic targets with drug candidates reached Phase III clinical testing, although death receptors "TRAIL" are closing the gap. The report projects that the competition targeting the IAP family of molecules will be intense and Caspase inhibitor will take a year or two to reach clinical tests.

"Analytical Tool - Apoptosis: Promise or deception" is the ultimate tool for serious players who would like to understand the current competitive field in apoptotic cancer drug development. With the "Basic Platform Report" and "R&D and Business Development CD-ROM database" you are provided with a complete and systematic description of the past and current efforts in the field. The included "Basic Platform report" CD-ROM database contains more than 2,000 records including detailed information about R&D, business interaction, breaking news, and company profiles. This highly updated database reflects the most recent advances in the field, in order to help you perform your own specific analysis and gives you the ability to present information in tables and graphs suited for your own specific purposes.

- This is the only product that provides you with a comprehensive picture of apoptopic targets and their agents in cancer therapeutics.
- It identifies and structures most B2B collaborations
- It covers close to all strategies in apoptopic cancer therapeutic
- You will be able to study areas in conjunction to cancer structured by therapy type, drug effects, mechanisms/targets and combinatory therapies
- It enables you to track cutting edge competitive companies, therapies and technologies in the future market
- You will save time and money by rapid identification and analysis of competitors and business opportunities.
- You will be able to evaluate progress in both established as well as novel treatment strategies competing within the field of cancer drug development in big pharma.

"Analytical Tool - Apoptosis: Promise or deception" offers a unique tool for analyzing the complex competitive pressure within this field. It is at the same time a map of the research and development, an up to date history of the achievements and a guide pointing out the directions of the future. This tool provides you with an immense amount of information organized and analyzed to assist you in your work.

This Analytical Tool includes three parts:
- Apoptosis: Promise or deception
- Basic Platform Report: Apoptosis
- Business Development and R&D Database: Apoptosis

For more information visit http://www.researchandmarkets.com/reports/c17635

Laura Wood
Senior Manager
Research and Markets
e-mail protected from spam bots
Fax: +353 1 4100 980





Research and Markets Apoptosis Promise Or Deception